Extendicare Inc.
EXE.TOTSXHealthcare● Active
$32.85
$-0.29(-0.88%)
Market Cap$3.1B
P/E Ratio—
52W High$35.62
52W Low$12.12
Extendicare Inc. (EXE.TO) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · EXE.TO · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.10B | $0.08B | $0.03B | $0.07B | $0.01B |
| Depreciation & Amort. | $0.04B | $0.03B | $0.03B | $0.03B | $0.04B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | $0.06B | $0.02B | ($0.04B) | $0.05B | $0.01B |
| Net Cash from Operations | $0.17B | $0.14B | $0.02B | $0.10B | $0.06B |
| Investing Activities | |||||
| Capital Expenditure | ($0.10B) | ($0.04B) | ($0.13B) | ($0.10B) | ($0.07B) |
| Purchases of Investments | ($0.00B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.06B | $0.03B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.12B) | ($0.01B) | ($0.08B) | $0.16B | ($0.06B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | ($0.01B) | ($0.04B) | $0.00B |
| Dividends Paid | ($0.04B) | ($0.04B) | ($0.04B) | ($0.04B) | ($0.04B) |
| Debt Issued / Repaid | $0.03B | ($0.04B) | $0.02B | ($0.11B) | ($0.03B) |
| Net Cash from Financing | $0.18B | ($0.09B) | ($0.03B) | ($0.19B) | ($0.07B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.06B | $0.10B | ($0.11B) | ($0.00B) | ($0.01B) |
| FCF Margin %(computed) | 3.82% | 6.94% | -8.13% | -0.23% | -0.52% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · CAD · B
Explore more Extendicare Inc. data
About Extendicare Inc. (EXE.TO) Cash Flow Statement
Extendicare Inc. generated operating cash flow of $0.17B and free cash flow of $0.06B for 2025 — a FCF margin of 3.82%. Capital expenditure was ($0.10B).
Frequently asked questions
EXE.TO · 4 questionsExtendicare Inc. generated free cash flow of $0.06B for 2025, down 37.7% year-over-year.
EXE.TO free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10